CSEM Diabetes & Endocrinology:
Perspectives on Practice Changing Research
Tuesday, January 23, 2024 | 19:00-20:30 ET | Online Session - Microsite
Moderated by Dr. Hertzel Gerstein, accredited online symposium features a review of the key scientific developments in endocrinology and diabetes over the past year. Our faculty will synthesize and discuss within the Canadian context research from major conferences.
Topics to be discussed include:
- Medical therapy for non-diabetes obesity to improve patient outcomes: Ongoing trials in prevention of diabetes, MAFLD, and cardiovascular events, and quality of life enhancement
- Novelties in hypoparathyroidism: Current and future therapies
- Novel approaches to insulin therapy: Challenges and opportunities with new basal insulins
- Benefits and risks of androgen replacement in middle-aged and older men with low testosterone levels
Learning Objectives
At the end of this symposium, participants will be able to:
- Review and synthesize key scientific developments in diabetes and endocrinology over the past year
- Evaluate the relevance and implications for diabetes management within a Canadian context
- Identify important elements of emerging research that can be applied to clinical practice
Faculty
Hertzel Gerstein, MD, MSc, FRCPC, McMaster University, Hamilton (Moderator)
Chris Tran, MD, FRCPC, MMEd, University of Ottawa, Ottawa (CPD Representative)
Heidi Dutton, MD, MSc, FRCPC, Dipl of ABOM, The Ottawa Hospital, Ottawa (Speaker)
Claudia Gagnon, MD, FRCPC, CHU de Québec-Université Laval, Laval (Speaker)
The session is free for CSEM members, and $60 for non-members. If you have not renewed your CSEM membership, please login and renew here.
This learning activity was planned independently by CSEM to achieve scientific integrity, objectivity, and balance. CSEM received educational grants from:
Lilly
Novo Nordisk
